Article Details
Retrieved on: 2024-03-04 15:20:39
Tags for this article:
Click the tags to see associated articles and topics
Summary
Sunshine Biopharma, a biotech company on NASDAQ, risks delisting as its stock, SBFM, traded below $1, and plans a 1-for-40 reverse split to comply with listing requirements. Trading volume has surged in response.
Article found on: investorplace.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here